• Introduced
    Jan 14, 2026
  • Passed House
    Feb 16, 2026
  • Passed Senate
  • Became Law
HB 1063
Virginia House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Opioid antagonist; distribution program, reports.
Last Action See all actions
Senate • Feb 26, 2026: Senate committee offered
Senate Calendar: 02/27/2026: Bills or Resolutions Rereferred - Notification
Position: 50

Summary

Comments on HB 1063

Tweets

Whip Lists

Sponsors
Votes
YES: 96

NO: 0

    YES: 97

    NO: 0

      Actions
      • Feb 26, 2026 | Senate
        • Reported from Education and Health with substitute and rereferred to Finance and Appropriations (15-Y 0-N)
        • Senate committee offered
      • Feb 24, 2026 | Senate
        • Assigned Education sub: Health
      • Feb 17, 2026 | Senate
        • Constitutional reading dispensed (on 1st reading)
        • Referred to Committee on Education and Health
      • Feb 16, 2026 | House
        • Read third time and passed House Block Vote (96-Y 0-N 0-A)
        • Reconsideration of passage agreed to by House
        • Passed House Block Vote (97-Y 0-N 0-A)
      • Feb 13, 2026 | House
        • Read second time and engrossed
      • Feb 12, 2026 | House
        • Read first time
      • Feb 10, 2026 | House
        • Reported from Health and Human Services (22-Y 0-N)
      • Feb 05, 2026 | House
        • Subcommittee recommends reporting (8-Y 0-N)
      • Jan 23, 2026 | House
        • Assigned sub: Behavioral Health
      • Jan 19, 2026 | House
        • Fiscal Impact Statement from Department of Planning and Budget (HB1063)
      • Jan 14, 2026 | House
        • Prefiled and ordered printed; Offered 01-14-2026 26103580D
        • Referred to Committee on Health and Human Services